Pharmaceutical products

Contract Value:: EUR 44M - 44M
Notice Type:: Contract award notice

Published Date:: 14 October 2015
Closing Date:

Location(s):: ITC45 Milano (IT Italy/ITALIA); ITC48 Pavia (IT Italy/ITALIA)

Description:: Appalto specifico in forma telematica aggregata per la fornitura di farmaci occorrenti all'Azienda Ospedaliera Luigi Sacco di Milano e alla Fondazione IRCCS Policlinico San Matteo di Pavia, per un periodo di 6 mesi.

Awarded to:: 38; , (); Abbvie Srl, (); Abbvie Srl, (); Abbvie Srl, (); Abbvie Srl, (); Allergan SpA, (); Amgen Srl, (); AstraZeneca SpA, (); AstraZeneca SpA, (); Bausch & Lomb IOM SpA, (); Baxalta Italy Srl, (); Baxalta Italy Srl, (); Baxalta Italy Srl, (); Bayer SpA, (); Bayer SpA, (); Bayer SpA, (); Biogen Italia Srl, (); Biogen Italia Srl, (); Boehringer Ingelheim Italia SpA, (); Bracco Imaging Italia, (); Bracco Imaging Italia, (); Bracco Imaging Italia, (); Bristol-Myers Squibb, (); Bristol-Myers Squibb, (); Bristol-Myers Squibb, (); Bristol-Myers Squibb, (); Bristol-Myers Squibb, (); Bristol-Myers Squibb, (); Bristol-Myers Squibb, (); Bristol-Myers Squibb, (); Bristol-Myers Squibb, (); Celgene Srl, (); Celgene Srl, (); Celgene Srl, (); Celgene Srl, (); Celgene Srl, (); Celgene Srl, (); CSL Behring SpA, (); CSL Behring SpA, (); Dompe' Farmaceutici SpA, (); Eli Lilly Italia SpA, (); Eli Lilly Italia SpA, (); Eli Lilly Italia SpA, (); Fresenius Kabi Italia Srl con unico socio, (); GE Healthcare Srl, (); Gilead Sciences Srl, (); Gilead Sciences Srl, (); Gilead Sciences Srl, (); Gilead Sciences Srl, (); GlaxoSmithKline SpA, (); GlaxoSmithKline SpA, (); Guerbet, (); Hikma Italia SpA, (); Hikma Italia SpA, (); Janssen-Cilag SpA, (); Janssen-Cilag SpA, (); Janssen-Cilag SpA, (); Janssen-Cilag SpA, (); Janssen-CIlag SpA, (); Janssen-Cilag SpA, (); Mallinckrodt Italia SpA, (); Merck Serono, (); MSD Italia Srl, (); MSD Italia Srl, (); MSD Italia Srl, (); MSD Italia Srl, (); Msd Italia Srl, (); Mundipharma Pharmaceuticals, (); Mylan SpA, (); Mylan SpA, (); Mylan SpA, (); Mylan SpA, (); Mylan SpA, (); Novartis Farma SpA, (); Novartis Farma SpA, (); Novartis Farma SpA, (); Novartis Farma SpA, (); Novartis Farma SpA, (); Novartis Farma SpA, (); Novartis Farma SpA, (); Novartis Farma SpA, (); Novartis Farma SpA, (); Novartis Farma SpA, (); Novartis Farma SpA, (); Novartis Farma SpA, (); Pfizer Italia Srl, (); Pfizer Italia Srl, (); Pfizer Italia Srl, (); Pfizer Italia Srl, (); Pfizer Italia Srl, (); Pfizer Italia Srl, (); Pfizer Srl, (); Pfizer Srl, (); Pfizer Srl, (); Pfizer Srl, (); Pfizer Srl, (); Pfizer Srl, (); Pierre Fabre Pharma Srl, (); Roche SpA Unipersonale, (); Roche SpA Unipersonale, (); Roche SpA Unipersonale, (); Roche SpA Unipersonale, (); Roche SpA Unipersonale, (); Roche SpA Unipersonale, (); Roche SpA Unipersonale, (); Roche SpA Unipersonale, (); Roche SpA Unipersonale, (); Roche SpA Unipersonale, (); Sanofi SpA, (); Sanofi SpA, (); Shire Italia SpA, (); Shire Italia SpA, (); Shire Italia SpA, (); Teva Italia Srl, (); Teva Italia Srl, (); UCB Pharma SpA, (); ViiV Healthcare Srl, (); ViiV Healthcare Srl, (); ViiV Healthcare Srl, (); ViiV Healthcare Srl, ()

: Download full details as .pdf

The Buyer:: Azienda Ospedaliera Luigi Sacco Polo Universitario

CPV Code(s):: 33600000 - Pharmaceutical products